Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.…
Hyperfine (HYPR) Q3 2026 Earnings Call Transcript
Hyperfine (NASDAQ: HYPR) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 102 employees.
The shares were at 0.5465 USD on 20 November 2026, down 48.9% over 52 weeks. Its 52-week range is 0.4881 USD to 1.935 USD: the price is 71.8% below the high and 12.0% above the low.
Its market capitalisation is 57.96M USD.
Hyperfine reports return on equity of -86.8%, an operating margin of -167.6% and revenue up 73.4% year over year.
It holds more cash than debt, a net cash position of 23.79M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 1.975 USD is 261.4% above the current price. The next earnings report is expected on 18 March 2027.